Blocking Galectin-3 with Modified Citrus Pectin Supports Cognition and May Help Prevent Alzheimer’s
Cognitive impairment and the development of Alzheimer’s disease are recognized risk factors in type 2 diabetes mellitus. Research continues to link metabolic dysregulation and specifically, insulin resistance, with Alzheimer’s disease and other forms of cognitive loss. Galectin-3 Fuels Diabetes and Cognitive Decline Emerging research into the beta-galactoside binding protein Galectin-3 (Gal-3) offersRead
